Skip to main content

What the FDA labels say about taking them together

Cyclosporine and darunavir

Darunavir's FDA label of August 29, 2025 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name darunavir. The darunavir label: “Therapeutic concentration monitoring of the immunosuppressive agent is recommended when co-administered with PREZISTA/ritonavir.”

Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the darunavir FDA label on DailyMed (effective August 29, 2025, Janssen Products LP).

What does the cyclosporine label say about darunavir?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name darunavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

What does the darunavir label say about cyclosporine?

Darunavir label, drug interactions

Concomitant Drug Class Drug Name Examples: Immunosuppressants: e.g. cyclosporine, tacrolimus, sirolimus; Effect on Concentration of Darunavir Or Concomitant Drug: ↑ immunosuppressants; Clinical Comment: Therapeutic concentration monitoring of the immunosuppressive agent is recommended when co-administered with PREZISTA/ritonavir.

Source: FDA drug label (PREZISTA), Janssen Products LP, effective August 29, 2025 (SPL set 814301f9-c990-46a5-b481-2879a521a16f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Cyclosporine generic labelers
13Darunavir generic labelers
CyclosporineDarunavir
Labeled forOrgan transplant rejection, Rheumatoid arthritisHIV
Boxed warningYesNo
Pharmacy cost (NADAC)$1.04 per unit 0.05% eye emulsion$1.16 per tablet 600 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?